Investor Center
Summit is publicly listed in the US (NASDAQ)


News
Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody
VIEW NEWS
Summit Therapeutics Appoints Experienced Clinical Leader Dr. Alessandra Cesano to its Board of Directors
VIEW NEWS
Share Price
NASDAQ: SMMT
At 31/05/2023 01:45
SEC Filings
Current report filing
VIEW FILING
Current report filing
VIEW FILING
Analyst Coverage
VisitShareholder Meetings
VisitCorporate Governance
The board believes that good corporate governance is integral to a successful business. We look to apply the highest standards of corporate governance appropriate to a company of our size and development stage, while balancing the need to ensure that the business has the correct level of skills and expertise required to manage a global company and fulfil our regulatory obligations into distinct jurisdictions.